Norges Bank’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-163,273
| Closed | -$3.39M | – | 2004 |
|
2023
Q3 | $3.39M | Sell |
163,273
-404,105
| -71% | -$8.39M | ﹤0.01% | 1754 |
|
2023
Q2 | $13.9M | Buy |
567,378
+9,466
| +2% | +$232K | ﹤0.01% | 1412 |
|
2023
Q1 | $22.7M | Sell |
557,912
-75,036
| -12% | -$3.05M | 0.01% | 1231 |
|
2022
Q4 | $28.5M | Buy |
632,948
+24,654
| +4% | +$1.11M | 0.01% | 1110 |
|
2022
Q3 | $29.1M | Sell |
608,294
-11,306
| -2% | -$541K | 0.01% | 1019 |
|
2022
Q2 | $36.7M | Buy |
619,600
+25,598
| +4% | +$1.52M | 0.01% | 927 |
|
2022
Q1 | $69.1M | Buy |
594,002
+4,614
| +0.8% | +$537K | 0.02% | 722 |
|
2021
Q4 | $88.7M | Buy |
589,388
+3,238
| +0.6% | +$487K | 0.02% | 665 |
|
2021
Q3 | $70M | Hold |
586,150
| – | – | 0.02% | 766 |
|
2021
Q2 | $57.1M | Buy |
586,150
+28,089
| +5% | +$2.74M | 0.01% | 894 |
|
2021
Q1 | $49.2M | Sell |
558,061
-59,522
| -10% | -$5.25M | 0.01% | 980 |
|
2020
Q4 | $59.1M | Sell |
617,583
-32,859
| -5% | -$3.14M | 0.01% | 863 |
|
2020
Q3 | $73.8M | Sell |
650,442
-106,208
| -14% | -$12.1M | 0.02% | 658 |
|
2020
Q2 | $74.8M | Sell |
756,650
-40,852
| -5% | -$4.04M | 0.02% | 626 |
|
2020
Q1 | $51.3M | Buy |
797,502
+273,000
| +52% | +$17.6M | 0.02% | 684 |
|
2019
Q4 | $31.3M | Sell |
524,502
-9,759
| -2% | -$582K | 0.01% | 1234 |
|
2019
Q3 | $31.5M | Hold |
534,261
| – | – | 0.01% | 1170 |
|
2019
Q2 | $34.5M | Buy |
534,261
+412,757
| +340% | +$26.6M | 0.01% | 1127 |
|
2019
Q1 | $7.72M | Buy |
+121,504
| New | +$7.72M | ﹤0.01% | 1874 |
|